Search

Emeis SA

Gesloten

11.05 -1.16

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

10.86

Max

11.45

Belangrijke statistieken

By Trading Economics

Inkomsten

-129M

Verkoop

1.4B

K/W

Sectorgemiddelde

0.021

Winstmarge

-9.273

Werknemers

51,071

EBITDA

106M

Aanbevelingen

By TipRanks

Aanbevelingen

Sell

12 Maanden Prognose

-19.93% downside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.8B

Vorige openingsprijs

12.21

Vorige sluitingsprijs

11.05

Emeis SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

1 jul 2025, 23:09 UTC

Winsten

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

1 jul 2025, 19:16 UTC

Acquisities, Fusies, Overnames

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

1 jul 2025, 23:47 UTC

Marktinformatie

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

1 jul 2025, 23:41 UTC

Marktinformatie

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

1 jul 2025, 22:23 UTC

Acquisities, Fusies, Overnames

James Hardie: Deal Represents Implied Value of $8.4 Billion

1 jul 2025, 22:23 UTC

Acquisities, Fusies, Overnames

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

1 jul 2025, 22:21 UTC

Acquisities, Fusies, Overnames

James Hardie Completes Acquisition of AZEK

1 jul 2025, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

1 jul 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

1 jul 2025, 20:24 UTC

Winsten

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

1 jul 2025, 19:55 UTC

Marktinformatie

Oil Futures Resume Cautious Rally -- Market Talk

1 jul 2025, 19:27 UTC

Marktinformatie

U.S. Natural Gas Futures Lose More Ground -- Market Talk

1 jul 2025, 19:12 UTC

Marktinformatie

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

1 jul 2025, 19:01 UTC

Acquisities, Fusies, Overnames

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

1 jul 2025, 18:41 UTC

Acquisities, Fusies, Overnames

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

1 jul 2025, 18:33 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

1 jul 2025, 18:33 UTC

Marktinformatie

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

1 jul 2025, 18:32 UTC

Marktinformatie

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

1 jul 2025, 18:22 UTC

Marktinformatie

Remittances to Mexico Down in May -- Market Talk

1 jul 2025, 17:45 UTC

Marktinformatie

Seasonal Demand Supports Further Oil Gains -- Market Talk

1 jul 2025, 17:01 UTC

Acquisities, Fusies, Overnames

Danone Completed Acquisition of Majority Stake in Kate Farms

1 jul 2025, 16:55 UTC

Winsten

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

1 jul 2025, 16:27 UTC

Marktinformatie

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

1 jul 2025, 16:25 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

1 jul 2025, 16:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

1 jul 2025, 15:48 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

1 jul 2025, 15:46 UTC

Marktinformatie

Global Equities Roundup: Market Talk

1 jul 2025, 15:46 UTC

Marktinformatie

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

1 jul 2025, 14:54 UTC

Marktinformatie

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

1 jul 2025, 14:49 UTC

Marktinformatie

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Emeis SA Prognose

Koersdoel

By TipRanks

-19.93% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 9 EUR  -19.93%

Hoogste 9 EUR

Laagste 9 EUR

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Emeis SA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Sell

1 ratings

0

Buy

0

Hold

1

Sell

Financieel

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

EBITDA

Operationele winst

$

Over Emeis SA

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. It operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. The company was founded in 1989 and is headquartered in Puteaux, France.